Maryland Health Care Product Development Corporation (MHCPDC)

Maryland Health Care Product Development Corporation (MHCPDC) has worked aggressively, since its inception in 1994, to identify promising technology investment candidates through a focused outreach program. In keeping with its first mission — to invest in early stage biomedical companies whose technology had history of federal/defense funding — the corporation has established working relationships with state, federal, and academic officials familiar with new technologies and the entrepreneurs driving their development.

The corporation's investments range in amounts from $250,000 to $1 million. MHCPDC expends significant efforts to identify and secure matching investments from commercial and state financing entities. MHCPDC's "partnership" approach to working with investment candidates is reflected in its ongoing, direct participation in the business development of its portfolio companies.

» Investment candidates are encouraged to review the MHCPDC Criteria page

MHCPDC Board of Directors

Chairman & President
Jerry L. Parrott

President and Chief Executive Officer
BioMarker Strategies

Investment Advisor to the Board

Blanche Johnson, Ph.D.

Investment Advisor
Maryland Health Care Product Development Corporation

Board Members

Kenneth C. Carter Ph.D.

President & Chief Executive Officer
Noble Life Sciences, Inc.

Steve Dubin

Chief Executive Officer
SDA Ventures, LLC

Edgar C. Harrell Ph.D.

Managing Partner
Harrell Partners LLC

Capers W. McDonald

Executive in Residence and Practitioner Faculty
Johns Hopkins University/MCC

Steven L. Meltzer

Partner
Pillsbury Winthrop Shaw Pittman LLP

Edward M. Rudnic, Ph.D.

Chief Operating Officer
QRxPharma


For additional information, contact:
MHCPDC
Blanche Johnson, Investment Advisor
9210 Corporate Boulevard, Suite 470
Rockville, MD 20850
bjohnson@techcouncilmd.com